Showing results (161-170 of 181) with videos related to
Sort By:
Pageof 19
NPJ Vaccines|November 30, 2021
Mucosal vaccination induces protection against SARS-CoV-2 in the absence of detectable neutralizing antibodiesChaojie Zhong, Hongjie Xia, Awadalkareem Adam, et al.Vaccine|March 12, 2018
Clinical development and regulatory points for consideration for second-generation live attenuated dengue vaccinesKirsten S Vannice, Annelies Wilder-Smith, Alan D T Barrett, et al.Emerging Infectious Diseases|February 24, 2006
Introductions of West Nile virus strains to MexicoEleanor Deardorff, José Estrada-Franco, Aaron C Brault, et al.Vaccine|September 11, 2019
Summit proceedings: Biomedical countermeasure development for emerging vector-borne viral diseasesMarcia A Blackman, Mark A Marchionni, John Gilly, et al.The Journal of General Virology|August 26, 2011
Envelope and pre-membrane protein structural amino acid mutations mediate diminished avian growth and virulence of a Mexican West Nile virus isolateStanley A Langevin, Richard A Bowen, Wanichaya N Ramey, et al.NPJ Vaccines|February 18, 2021
A genetically stable Zika virus vaccine candidate protects mice against virus infection and vertical transmissionAwadalkareem Adam, Camila R Fontes-Garfias, Vanessa V Sarathy, et al.Emerging Infectious Diseases|January 15, 2004
West Nile virus in Mexico: evidence of widespread circulation since July 2002José G Estrada-Franco, Roberto Navarro-Lopez, David W C Beasley, et al.Vaccine|February 26, 2024
Vaccine value profile for ChikungunyaXimena Flandes, Clairissa A Hansen, Sunil Palani, et al.NPJ Vaccines|November 6, 2023
Identification of the flavivirus conserved residues in the envelope protein hinge region for the rational design of a candidate West Nile live-attenuated vaccineBailey E Maloney, Kassandra L Carpio, Ashley N Bilyeu, et al.Vaccine|November 6, 2025
Summary of human West Nile virus vaccine meeting, 2024: Investigating barriers to developmentRandall J Nett, Aaron C Brault, Amy J Lambert, et al.Pageof 19